INmune Bio (INMB) Q2 Loss Widens 110% - The Globe and Mail

Retrieved on: 2025-08-07 23:25:56

Tags for this article:

Click the tags to see associated articles and topics

INmune Bio (INMB) Q2 Loss Widens 110% - The Globe and Mail. View article details on hiswai:

Excerpt

INmune Bio(NASDAQ:INMB) is developing therapies that leverage the innate immune system—a branch of immunity that forms the body's first line of ...

Article found on: www.theglobeandmail.com